Trial investigator Emma Guttman, MD, PhD, chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, here explains why targeting the OX40-OX40 ligand pathway is so exciting ...
The industry would rather not talk about this task. But tiptoeing around it and avoiding the term only fuels misinformation about a process largely shaped by regulatory demands ...
inews.co.uk on MSN
Are antiperspirants dangerous? Experts break down the facts
Deodorant and antiperspirants have had their fair share of bad press, with rumours abounding that they cause cancer and Alzheimer’s disease, block toxins from escaping our bodies, and contain harmful ...
He once styled Nicole Kidman and Naomi Watts, but Daniel Skinner has swapped the glamour of celebrity hairdressing for a very ...
VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...
China Medical System (CHSYF) announces that its subsidiaries, Dermavon Holdings, obtained positive results from the phase 3 clinical trial of ...
WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) cream 1.5% for children as young as two with mild to moderate ...
An infestation can often be confused with dandruff or seborrheic dermatitis. Becky Boudreau, a head lice technician in New ...
The Trial is a randomized, double-blind, placebo-controlled, multi-centre clinical trial, with 192 patients enrolled in total, aiming to evaluate the safety and efficacy of the Product in patients ...
Tanaka, Y. , Aganahi, A. and Parker, R. (2025) Actinic Damage: The Major Cause of Skin Aging. Journal of Cosmetics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback